Categories: News

VivaLNK Offers Untethered Wearable ECG Monitor Solution for Six-Minute Walk Test

CAMPBELL, Calif., Feb. 16, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, announces availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT). The 6MWT is a common exercise routine used for patients with pulmonary hypertension, congestive heart failure, pre-lung transplant evaluation, interstitial lung disease, or COPD. It involves monitoring a patient while they walk as far as they can in a six-minute period and assessing cardiopulmonary function.

The VivaLNK solution is used for clinical research in a variety of applications, such as cardiac rehab, digital biomarkers of arrhythmia onset, and pharmaceutical clinical trials, and includes a wearable ECG patch, a specialized mobile app, and cloud data services. In these studies, patients wear the wireless ECG patch while a clinician is able to monitor and control the test using a mobile app. Data collected during the test is then consolidated into a centralized database in the cloud for post analysis.

In one study, up to 80 subjects across multiple sites are monitored for their ECG and heart rate before, during and after the exercise. A significant part of the technology selection includes device comfort for the patient and stability of the ECG during movement, as well as a mobile app designed for the protocol. At only 7.5 grams, VivaLNK’s unique wearable ECG monitor is barely noticeable when worn. In addition, special built-in algorithms reduce motion artifacts to provide a smooth ECG signal during activity. For the study, VivaLNK also customized a mobile app to facilitate data capture even in the event of intermittent network disconnections.

“Medical wearables are making it possible to explore new, potentially meaningful outcomes in clinical studies without adding much additional burden to patients or their clinicians,” says Robert F. Roscigno, PhD, Vice President, Clinical Development at Gossamer Bio.

Aside from the 6MWT, VivaLNK’s medical data platform and wearable sensors are used in other applications such as mobile cardiac telemetry, oncology RPM, and virtual hospital patient monitoring.

For more information on VivaLNK’s full line of medical wearable sensors and data services visit: https://www.vivalnk.com/.

About VivaLNK
VivaLNK is a provider of connected healthcare solutions for remote patient monitoring. We leverage unique physiology-optimized medical wearable sensors and data services to enable a deeper and more clinical relationship between provider and patient.

Media Contact:
pr@VivaLNK.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/vivalnk-offers-untethered-wearable-ecg-monitor-solution-for-six-minute-walk-test-301228356.html

SOURCE VivaLNK

Staff

Recent Posts

How Luciana Preger Is Helping Advance Gilead’s Work in Oncology

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Gilead SciencesLuciana Preger credits being exposed…

10 mins ago

Clearstep Unveils Advanced Self-Service Booking for Specialist Care

New AI-driven technology integration marks a first in the U.S., enhancing patient access to specialized…

10 mins ago

Rutherrin(R) Increases Efficacy of Chemotherapy

TORONTO, ON / ACCESSWIRE / June 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…

10 mins ago

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s…

11 mins ago